Bristol Myers’ M&A Lawyer Breaks Down Its Holiday Deal Spree
The Bristol Myers Squibb
Photographer: Adam Glanzman/BloombergThis article is for subscribers only.
Hi, it’s Michelle F. Davis, chatting today with a top lawyer behind a string of major health-care deals about what she sees ahead for M&A. We also have news on a potential Boeing acquisition and Trump’s SPAC.
Today's top stories
Catherine Dargan is the M&A lawyer behind Bristol Myers Squibb’s $18 billion burst of deals in December, one of which was signed on Christmas day.